ROCKETVAX
LIVE

Serial Number

79363621

Owner

RocketVax AG

Attorney

Dwayne K. Goetzel

Filing Date

Nov 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ROCKETVAX Trademark

Serial Number: 79363621 • Registration: 7307495

ROCKETVAX is a trademark filed by RocketVax AG on November 4, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

RocketVax AG

Rittergasse 3

Entity Type: 25

Trademark Details

Filing Date

November 4, 2022

Registration Date

February 20, 2024

Published for Opposition

December 5, 2023

Goods & Services

Industrial chemicals; chemical preparations for scientific purposes; active chemical ingredients used in the manufacture of anti-cancer drugs

Pharmaceutical products, substances and preparations in particular for the prevention and treatment of infectious and cancerous diseases; vaccines, in particular viral and DNA-based and RNA-based vaccines; preparations for vaccines; adjuvants and additives for vaccines; additives for vaccines; biochemical substances for medical or veterinary use, namely, for the prevention and treatment of infectious and cancerous diseases; synthetic DNA for medical or veterinary use, namely, for the prevention and treatment of infectious and cancerous diseases; pharmaceutical diagnostic agents for medical use; pharmaceutical preparations and compositions for cancer treatment and cancer prevention

Medical services; pharmaceutical compounding consultant services; medical and pharmaceutical compounding services; preparation of medical and pharmaceutical reports with respect to treatment of individuals; performing RNA and DNA analyses for medical and veterinary purposes relating to the treatment of patients; conducting medical analysis relating to the treatment of patients; medical testing for diagnostic or treatment purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment; advice concerning all the aforesaid services

Research and development in the fields of biology, pharmacy, immunology, oncology, DNA-based technologies, genetic engineering and vaccines; scientific research and development for medical purposes in the field of cancerous diseases; DNA verification in the nature of DNA screening for scientific research purposes; conducting and evaluation of scientific feasibility studies, in particular medical and pharmaceutical studies; development of diagnostic methods and testing procedures; preparation of scientific reports; advice concerning all the aforesaid services

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 12, 2026 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 11, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 18, 2024 FICS
FINAL DISPOSITION PROCESSED
Jul 18, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 20, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 20, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 5, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Dec 4, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 15, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 15, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 19, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 11, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 15, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 15, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 26, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 25, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 21, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 23, 2023 REPR